Marker Vaccine - an overview | ScienceDirect Topics
Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection—A comparative study from Novi Sad, Serbia | PLOS ONE
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models - ScienceDirect
DIVA (Differentiating Infected from Vaccinated Animals) vaccines and strategies
DNA vaccine - Wikipedia
Accepted Manuscript
Semisynthetic Glycoconjugate Vaccine Candidates against Escherichia coli O25B Induce Functional IgG Antibodies in Mice | JACS Au
Frontiers | Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines
Vaccines | Free Full-Text | A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies
Development of a novel marker vaccine platform for protection against Bluetongue Virus (BTV) - BORIS Theses
Carbohydrates and Immunology: Synthetic Oligosaccharide Antigens for Vaccine Formulation - Morelli - 2011 - European Journal of Organic Chemistry - Wiley Online Library
FAQ: DIVA vaccines and diagnostics - Epizone
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development | ACS Central Science
Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial - The Lancet Infectious Diseases
1. The marker vaccine principle (after Franken, 2009a,b). | Download Scientific Diagram
Recombinant Vaccine
Advances in COVID-19 mRNA vaccine development | Signal Transduction and Targeted Therapy
Figure 10 from Third generation DIVA vaccine towards classical swine fever virus. Efficacy in face of maternal immunity | Semantic Scholar
Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle | ACS Nano
Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2: Molecular Therapy
Vaccines | Free Full-Text | Methods for Measuring T-Cell Memory to Vaccination: From Mouse to Man
Memory B cell diversity: insights for optimized vaccine design: Trends in Immunology
Revisiting the Principles of Designing a Vaccine | SpringerLink
Viruses | Free Full-Text | Comparative Study of Optical Markers to Assess Bait System Efficiency Concerning Vaccine Release in the Oral Cavity of Dogs
Biobos IBR Marker Vaccine
Learning from the past: development of safe and effective COVID-19 vaccines | Nature Reviews Microbiology
The effect of an mRNA vaccine against COVID-19 on endothelial function and arterial stiffness | Hypertension Research
